<prompt> Answer this question truthfullyWhat is the target of Ranibizumab and Bevacizumab, and what is their mechanism of action?  <response>: <reason> Ranibizumab and Bevacizumab are monoclonal antibodies against Vascular Endothelial Growth Factor VEGF, which prevents the growth of blood vessels. 